BRIEF published on 03/10/2025 at 14:51, 1 year ago Genel Energy Enters Exploration Agreement in Oman Genel Energy Strategic Diversification Exploration Investment Oman Agreement Block 54
BRIEF published on 03/10/2025 at 14:22, 1 year ago Crossject: Update on voting rights and shares as of January 31, 2025 Share Capital Voting Rights Actions Pharmaceutical Crossject
BRIEF published on 03/10/2025 at 14:05, 1 year ago Greenliant Showcases Durable Industrial SSDs at Embedded World 2025 Greenliant High Endurance Embedded World 2025 Industrial SSDs Memory Cards
BRIEF published on 03/10/2025 at 14:05, 1 year ago Avant Technologies and Ainnova Collaborate with Apollo Hospitals to Boost AI in Healthcare AI In Healthcare Global Collaboration Chronic Disease Detection Vision AI Platform Apollo Hospitals
BRIEF published on 03/10/2025 at 14:05, 1 year ago TuHURA Biosciences to Present at ROTH Conference TuHURA Biosciences Immuno-oncology ROTH Conference Cancer Resistance IFx-2.0 Trial
BRIEF published on 03/10/2025 at 13:50, 1 year ago Crédit Agricole Brie Picardie: Summary of Share Buybacks According to the MAR Regulation Kepler Cheuvreux Share Buybacks XPAR Market MAR Regulations Agricultural Credit
BRIEF published on 03/10/2025 at 13:35, 1 year ago Volcon Announces $2 Million Share Repurchase Program Share Repurchase Electric Vehicles Market Conditions Financial Strategy Volcon
BRIEF published on 03/10/2025 at 13:24, 1 year ago ALTAREIT: Information on Voting Rights and Share Capital Share Capital Voting Rights Treasury Shares Threshold Crossing Mandatory Declaration
BRIEF published on 03/10/2025 at 13:22, 1 year ago Summary of ALTAREIT's Monthly Transactions on its Own Securities in February 2025 Securities Liquidity Contract Transactions ALTAREIT February 2025
BRIEF published on 03/10/2025 at 13:20, 1 year ago Protagonist Therapeutics Reports Promising Results for Ulcerative Colitis Treatment Ulcerative Colitis Phase 2b Study Icotrokinra Clinical Response IL-23 Receptor
Published on 03/23/2026 at 08:00, 1 hour 48 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 7 hours 48 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 09:19, 29 minutes ago Mister Spex Chooses Salesforce to further develop its Omnichannel Strategy
Published on 03/23/2026 at 09:00, 48 minutes ago EQS Group launches Risk Management module to support continuous data and AI risk oversight
Published on 03/20/2026 at 19:00, 2 days 14 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 15 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 2 days 16 hours ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 15 hours ago Filing of the 2025 Universal Registration Document
